山东大学耳鼻喉眼学报 ›› 2021, Vol. 35 ›› Issue (6): 108-112.doi: 10.6040/j.issn.1673-3770.0.2020.493
周宇翔1,2,苗北平1,卢永田1
ZHOU Yuxiang1.2,MIAO Beiping1, LU Yongtian1
摘要: 鼻咽癌发病率居头颈部肿瘤的首位。治疗方式首选以放疗为主的综合治疗,如诱导化疗、同期化疗、分子靶向治疗、手术等。随着内镜技术及鼻颅底手术在临床的开展以及鼻咽癌的早期诊断的改进,鼻咽癌治疗方式得到了新的发展,头颈外科医生逐渐将内镜微创的手术理念应用于首诊鼻咽癌患者,目的在于提高患者生活质量以及生存率。将对近年来首诊鼻咽癌内镜微创手术治疗现状及进展进行阐述。
中图分类号:
[1] 罗秀玲, 金风, 毕婷, 等. TPF方案诱导化疗不同给药方式联合调强放疗治疗局部晚期鼻咽癌的中期疗效及预后分析[J]. 中华放射医学与防护杂志, 2018, 38(8): 595-601. doi:10.3760/cma.j.issn.0254-5098.2018.08.007. LUO Xiuling, JIN Feng, BI Ting, et al. Mid-term efficacy and prognosis of TPF regimen induction chemotherapy combined with IMRT for locally advanced nasopharyngeal carcinoma[J]. Chin J Radiol Med Prot, 2018, 38(8): 595-601. doi:10.3760/cma.j.issn.0254-5098.2018.08.007. [2] 余洪猛, 孙希才, 宋小乐. 复发性鼻咽癌内镜手术治疗现状[J]. 中国现代神经疾病杂志, 2019, 19(4): 226-231. doi:10.3969/j.issn.1672-6731.2019.04.003. YU Hongmeng, SUN Xicai, SONG Xiaole. Current situation of endoscopic surgery for recurrent nasopharyngeal carcinoma[J]. Chin J Contemp Neurol Neurosurg, 2019, 19(4): 226-231. doi:10.3969/j.issn.1672-6731.2019.04.003. [3] King WWK, Ku PKM, Mok CO, et al. Nasopharyngectomy in the treatment of recurrent nasopharyngeal carcinoma: a twelve-year experience[J]. Head Neck, 2000, 22(3): 215-222. doi:10.1002/(sici)1097-0347(200005)22: 3<215: aid-hed2>3.0.co;2-b. [4] 邱前辉, 李娜, 张秋航, 等. 内镜手术治疗首诊局部晚期鼻咽癌的疗效分析[J]. 中华耳鼻咽喉头颈外科杂志, 2017, 52(5): 365-371. doi:10.3760/cma.j.issn.1673-0860.2017.05.009. QIU Qianhui, LI Na, ZHANG Qiuhang, et al. Clinical efficacy of endoscopic nasopharyngectomy for initially diagnosed advanced nasopharyngeal carcinoma[J]. Chin J Otorhinolaryngol Head Neck Surg, 2017, 52(5): 365-371. doi:10.3760/cma.j.issn.1673-0860.2017.05.009. [5] 王剑祁, 李刚, 韩日, 等. 局部复发性鼻咽癌挽救性手术治疗[J]. 临床耳鼻咽喉头颈外科杂志, 2016,30(22): 1823-1826. doi:10.13201/j.issn.1001-1781.2016.22.023. WANG Jianqi, LI Gang, HAN Ri, et al. Salvage surgical treatment for local recurrent nasopharyngeal cancer[J]. J Clin Otorhinolaryngol Head Neck Surg, 2016,30(22): 1823-1826. doi:10.13201/j.issn.1001-1781.2016.22.023. [6] 吴双, 郎锦义, 李志琳, 等. 复发性鼻咽癌再次放疗182例临床分析[J]. 四川医学, 2000, 21(3): 199-201. doi:10.16252/j.cnki.issn1004-0501-2000.03.006. WU Shuang, LANG Jinyi, LI Zhilin, et al. Re-irradiation of recurrent nasopharyngeal carcinoma[J]. Sichuan Med J, 2000, 21(3): 199-201. doi:10.16252/j.cnki.issn1004-0501-2000.03.006. [7] Lee AW, Law SC, Foo W, et al. Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976-1985: survival after local recurrence[J]. Int J Radiat Oncol Biol Phys, 1993, 26(5): 773-782. doi:10.1016/0360-3016(93)90491-d. [8] Yoshizaki T, Wakisaka N, Murono S, et al. Endoscopic nasopharyngectomy for patients with recurrent nasopharyngeal carcinoma at the primary site[J]. Laryngoscope, 2005, 115(8): 1517-1519. doi:10.1097/01.MLG.0000165383.35100.17. [9] You R, Zou X, Hua YJ, et al. Salvage endoscopic nasopharyngectomy is superior to intensity-modulated radiation therapy for local recurrence of selected T1-T3 nasopharyngeal carcinoma-A case-matched comparison[J]. Radiother Oncol, 2015, 115(3): 399-406. doi:10.1016/j.radonc.2015.04.024. [10] Simo R, Robinson M, Lei M, et al. Nasopharyngeal carcinoma: united kingdom national multidisciplinary guidelines[J]. J Laryngol Otol, 2016, 130(S2): S97-S103. doi:10.1017/S0022215116000517. [11] 中国抗癌协会鼻咽癌专业委员会,林少俊,陈晓钟, 等.复发鼻咽癌治疗专家共识[J].中华放射肿瘤学志, 2018, 27(1): 16-22. doi:10.3760/cma.j.issn.1004-4221.2018.01.004. nasopharyngeal carcinoma[J]. Laryngoscope, 2007, 117(5): 894-896. doi:10.1097/MLG.0b013e3180381644. [12] 刘全, 孙希才, 于华鹏, 等. 鼻内镜下鼻咽癌切除术的手术分型[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 39-45. doi: 10.6040/j.issn.1673-3770.1.2019.016. LIU Quan, SUN Xicai, YU Huapeng, et al. Types of endoscopic transnasal nasopharyngectomy for nasopharyngeal carcinoma[J]. J Otolaryngol Ophthalmol Shandong Univ, 2019, 33(2): 39-45. doi: 10.6040/j.issn.1673-3770.1.2019.016. [13] Liu J, Yu HP, Sun XC, et al. Salvage endoscopic nasopharyngectomy for local recurrent or residual nasopharyngeal carcinoma: a 10-year experience[J]. Int J Clin Oncol, 2017, 22(5):834-842. doi: 10.1007/s10147-017-1143-9. [14] Chan KCA, Woo JKS, King A, et al. Analysis of plasma Epstein-Barr virus DNA to screen for nasopharyngeal cancer[J]. N Engl J Med, 2017, 377(6): 513-522. doi:10.1056/nejmoa1701717. [15] Ji MF, Huang QH, Yu X, et al. Evaluation of plasma epstein-barr virus DNA load to distinguish nasopharyngeal carcinoma patients from healthy high-risk populations in Southern China[J]. Cancer, 2014, 120(9): 1353-1360. doi:10.1002/cncr.28564. [16] Zhang MX, Li J, Shen GP, et al. Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-up[J]. Eur J Cancer, 2015, 51(17): 2587-95. doi: 10.1016/j.ejca.2015.08.006. [17] Su SF, Han F, Zhao C, et al. Long-term outcomes of early-stage nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy alone[J]. Int J Radiat Oncol Biol Phys,2012,82(1):327-33. doi: 10.1016/j.ijrobp.2010.09.011. [18] 司勇锋, 陶仲强, 张政, 等. 手术联合同步放化疗治疗早期鼻咽癌的前瞻性研究[J]. 临床耳鼻咽喉头颈外科杂志, 2012, 26(9): 422-425. doi: 10.3969/j.issn.1672-5085.2012.48.323. SI Yongfeng, TAO Zhongqiang, ZHANG Zheng, et al. A prospective study of surgery combined with concurrent radiochemotherapy in the treatment of patients with early stage nasopharyngeal carcinoma[J]. Journal of Clinical Otorhinolaryngology, 2012, 26(9): 422-425. doi: 10.3969/j.issn.1672-5085.2012.48.323. [19] Liu YP, Xie YL, Zou X, et al. Techniques of endoscopic nasopharyngectomy for localized stage I nasopharyngeal carcinoma[J]. Head Neck, 2020, 42(4): 807-812. doi:10.1002/hed.26090. [20] Liu YP, Lv X, Zou X, et al. Minimally invasive surgery alone compared with intensity-modulated radiotherapy for primary stage I nasopharyngeal carcinoma[J]. Cancer Commun(Lond), 2019, 39(1): 75. doi:10.1186/s40880-019-0415-3. [21] 赵丽娟, 姜彦, 于龙刚, 等. 鼻咽癌内镜手术治疗临床分析[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 51-56. doi:10.6040/j.issn.1673-3770.0.2019.073. ZHAO Lijuan, JIANG Yan, YU Longgang, et al. Clinical analysis of endoscopic surgery for nasopharyngeal carcinoma[J]. J Otolaryngol Ophthalmol Shandong Univ, 2019, 33(2): 51-56. doi:10.6040/j.issn.1673-3770.0.2019.073. [22] Weng JJ, Wei JZ, Li M, et al. Effects of surgery combined with chemoradiotherapy on short- and long-term outcomes of early-stage nasopharyngeal carcinoma[J]. Cancer Manag Res, 2020, 12: 7813-7826. doi:10.2147/CMAR.S262567. [23] Huang Y, Qiu QH. Endoscopic surgery for early-stage nasopharyngeal carcinoma: a justified initial option[J]. Acta Otolaryngol, 2017, 137(11): 1194-1198. doi:10.1080/00016489.2017.1351041. [24] Lee CC, Huang TT, Lee MS, et al. Clinical application of tumor volume in advanced nasopharyngeal carcinoma to predict outcome[J]. Radiat Oncol, 2010, 5: 20. doi:10.1186/1748-717x-5-20. [25] Wu Z, Su Y, Zeng RF, et al. Prognostic value of tumor volume for patients with nasopharyngeal carcinoma treated with concurrent chemotherapy and intensity-modulated radiotherapy[J]. J Cancer Res Clin Oncol, 2014, 140(1): 69-76. doi:10.1007/s00432-013-1542-x. [26] 邱前辉, 陈卓. 鼻内镜手术治疗首诊局部晚期鼻咽癌及放疗后严重并发症的作用[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 17-20. doi:10.6040/j.issn.1673-3771.1.2019.012. QIU Qianhui, CHEN Zhuo. Endoscopic surgery for the treatment of locally advanced nasopharyngeal carcinoma and serious complications after radio-therapy[J]. J Otolaryngol Ophthalmol Shandong Univ, 2019, 33(2): 17-20. doi:10.6040/j.issn.1673-3771.1.2019.012. [27] 邱前辉, 高俊潇. 鼻咽癌外科治疗的历史与现状及展望[J]. 中国耳鼻咽喉颅底外科杂志, 2020, 26(5): 473-477. doi:10.11798/j.issn.1007-1520.202005001. QIU Qianhui, GAO Junxiao. The history, current situation and prospect of surgery of nasopharyngeal carcinoma[J]. Chin J Otorhinolaryngol - Skull Base Surg, 2020, 26(5): 473-477. doi:10.11798/j.issn.1007-1520.202005001. [28] Ozer E, Waltonen J. Transoral robotic nasopharyngectomy: a novel approach for nasopharyngeal lesions[J]. Laryngoscope, 2008, 118(9): 1613-1616. doi:10.1097/MLG.0b013e3181792490. [29] Wei WI, Ho WK. Transoral robotic resection of recurrent nasopharyngeal carcinoma[J]. Laryngoscope, 2010, 120(10): 2011-2014. doi:10.1002/lary.21059. [30] Tsang RK, To VS, Ho AC, et al. Early results of robotic assisted nasopharyngectomy for recurrent nasopharyngeal carcinoma[J]. Head Neck, 2015, 37(6): 788-793. doi:10.1002/hed.23672. [31] Chan JYW, Wei WI. Three-dimensional endoscopy for endoscopic salvage nasopharyngectomy: Preliminary report of experience[J]. Laryngoscope, 2018, 128(6): 1386-1391. doi:10.1002/lary.26993. |
[1] | 李定波,唐志元,邓智毅,曾宪海,张秋航,王再兴. 低温等离子射频消融术治疗药物性鼻炎27例[J]. 山东大学耳鼻喉眼学报, 2022, 36(5): 11-17. |
[2] | 朱晶,张睿,赵媛,李炀,樊孟耘,赵昱. 内镜下低温等离子消融治疗不同炎症分期先天性梨状窝瘘45例[J]. 山东大学耳鼻喉眼学报, 2022, 36(5): 24-29. |
[3] | 李利杰,田秀芬. CO2激光联合低温等离子治疗早期声门型喉癌40例[J]. 山东大学耳鼻喉眼学报, 2022, 36(4): 79-85. |
[4] | 王欢,胡俐,余洪猛. 慢性鼻窦炎相关嗅觉功能障碍研究进展[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 43-49. |
[5] | 资昊坤,肖旭平,李云秋. 口服糖皮质激素在慢性鼻窦炎伴鼻息肉围手术期的应用现状[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 98-103. |
[6] | 曹轩,肖旭平,李云秋. 透明质酸在慢性鼻窦炎中的研究进展[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 104-109. |
[7] | 秦铭,孙占伟,王卫卫,李世超,武天义,王广科. 咽喉反流症状或体征评分阳性的慢性鼻窦炎患者鼻内镜术后碱性等渗盐水冲洗的疗效观察[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 147-153. |
[8] | 陈世琴,卫平存,胡云龙,胡金旺. 糖皮质激素三种不同鼻用法对鼻内镜术后黏膜转归的影响[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 195-201. |
[9] | 华红利,李松,陶泽璋. 人工智能在鼻咽癌诊疗中的研究进展[J]. 山东大学耳鼻喉眼学报, 2022, 36(2): 113-119. |
[10] | 陈坤,陆慧,黄琦,李磊,孟国珍,杨军,侯东明. 小儿先天性鼻腔鼻窦肿物的临床诊疗观察[J]. 山东大学耳鼻喉眼学报, 2022, 36(1): 81-85. |
[11] | 黄桂亮,孙昌志,罗仁忠,陈彦球,刘少锋,许家健. 内镜在婴幼儿舌根囊肿手术中的临床应用分析[J]. 山东大学耳鼻喉眼学报, 2022, 36(1): 100-105. |
[12] | 芦晓妍, 温树信. 先天性后鼻孔闭锁的治疗进展[J]. 山东大学耳鼻喉眼学报, 2022, 36(1): 138-142. |
[13] | 张旻, 刘永亮, 宋道亮, 韩学锋, 封新荣, 赵允沛. 鼻内镜下改良下鼻甲成形术与下鼻甲低温等离子消融加骨折外移术治疗重度慢性肥厚性鼻炎的临床对比研究[J]. 山东大学耳鼻喉眼学报, 2021, 35(6): 83-88. |
[14] | 冯成敏,敬一丹,刘海,王冰. 咽喉部鳞状细胞癌细胞系[J]. 山东大学耳鼻喉眼学报, 2021, 35(6): 113-124. |
[15] | 秦贺,万宝刚,王洪丽,赵本绮. CT检查在真菌球型鼻窦炎术前诊断中的临床意义[J]. 山东大学耳鼻喉眼学报, 2021, 35(5): 32-35. |
|